Athyrium Opportunities Ii Co-Invest 1 Lp, Shareholder at HLS Therapeutics Inc, holds 3.05M shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, Athyrium Opportunities Ii Co-Invest 1 Lp Sold C$1,300,000 shares of HLS Therapeutics Inc on Jul 05, 2023 for an estimated value of 7.51M.